Outcome of patients with hormone-refractory prostate cancer: prognostic significance of prostate-specific antigen-doubling time and nadir prostate-specific antigen.

Source:http://linkedlifedata.com/resource/pubmed/id/18258713

Download in:

View as

General Info

PMID
18258713